Monitoring disease progression in follicular lymphoma with next-gen sequencing

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Pathology

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Daniel J Sargent

Methodology for Development, Validation, and Use of Novel Endpoints in Oncology

Non-Hodgkin lymphoma Colorectum

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

John B Sunwoo

Enhancement of Natural Killer Cell Effector Functions

Non-Hodgkin lymphoma Hodgkin lymphoma

Carlos Rodriguez-Galindo

Capacity Building Program

Sarcoma Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Roberto Chiarle

Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

David Twa

The significance of recurrent translocations involving programmed death ligands in non-Hodgkin lymphomas

Non-Hodgkin lymphoma